Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke

NCT01623622 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Upper Limb Hemiplegia

Interventions

DRUG: HC-58
DRUG: Placebo

Sponsor

Asahi Kasei Therapeutics Corporation